Profile of blonanserin for the treatment of schizophrenia
Tomomi Tenjin, Seiya Miyamoto, Yuriko Ninomiya, Rei Kitajima, Shin Ogino, Nobumi Miyake, Noboru YamaguchiDepartment of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Kanagawa, JapanAbstract: Blonanserin was developed as an antipsychotic drug in Japan and approved for the treat...
Saved in:
Main Authors: | Tenjin T, Miyamoto S, Ninomiya Y, Kitajima R, Ogino S, Miyake N, Yamaguchi N |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/e302a7e69eba4fb2b7c5fc3a1d82f6ed |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early prediction of blonanserin response in Japanese patients with schizophrenia
by: Kishi T, et al.
Published: (2014) -
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
by: Kishi T, et al.
Published: (2016) -
Profile of minocycline and its potential in the treatment of schizophrenia
by: Zhang L, et al.
Published: (2014) -
Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
by: Okazaki K, et al.
Published: (2016) -
Role of aripiprazole in treatment-resistant schizophrenia
by: Mossaheb N, et al.
Published: (2012)